Trevi Therapeutics (TRVI) Stock: Buy, Sell, or Hold?
TRVI - Trevi Therapeutics, Inc. Common Stock
$12.94
0.17 (1.33%)
▲
5d:
+6.85%
30d:
-10.51%
90d:
-26.2%
BUY
HIGH Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 12, 2026
19d
Get Alerted When TRVI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TRVI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: TRVI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: TRVI is currently trading at $12.94, which is considered slightly low relative to its 30-day fair value range of $12.63 to $14.93.
Technical Outlook: Technically, TRVI is in a downtrend. Immediate support is located at $11.70, while resistance sits at $13.46.
Market Sentiment: TRVI scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.18 (+117.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TRVI is in a downtrend. Immediate support is located at $11.70, while resistance sits at $13.46.
Market Sentiment: TRVI scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.18 (+117.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$12.63 -
$14.93
Company Quality Score
69/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (92/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 117.8% below Wall St target ($28.18)
- BULLISH: Bottoming setup score 92/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$12.63 -
$14.93
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$11.70
Resistance Level
$13.46
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-22.43
Wall Street Target
$28.18
(+117.8%)
Share & Embed Analysis
Last updated: October 23, 2026 12:09 AM ET
Data refreshes hourly during market hours. Next update: 1:09 AM
Data refreshes hourly during market hours. Next update: 1:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRVI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 61 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 66 BUY |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 64 BUY |
Advanced TRVI Option Strategies
Professional options setups generated by AI based on today's TRVI price and gamma walls.
